Manhattan Psychiatric Center; Psychopharmacology Research Unit — New York, New York

Manhattan Psychiatric Center; Psychopharmacology Research Unit is a clinical research site located in New York, New York, United States 10035.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Manhattan Psychiatric Center; Psychopharmacology Research Unit has participated in 2 clinical trials.

Therapeutic areas: Schizophrenia, Schizophrenia, Schizoaffective Disorder.

Sponsors: Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Manhattan Psychiatric Center; Psychopharmacology Research Unit?

Manhattan Psychiatric Center; Psychopharmacology Research Unit has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Manhattan Psychiatric Center; Psychopharmacology Research Unit conducted?

Manhattan Psychiatric Center; Psychopharmacology Research Unit has 2 clinical trials on record. Their work covers Schizophrenia, Schizophrenia, Schizoaffective Disorder.

Is Manhattan Psychiatric Center; Psychopharmacology Research Unit accredited by Crixeo Health?

Manhattan Psychiatric Center; Psychopharmacology Research Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Manhattan Psychiatric Center; Psychopharmacology Research Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.